Enzo Veltri Selected Research

Enzo Veltri Research Topics

Disease

14	Neoplasms (Cancer) 04/2021 - 09/2005
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 08/2003
7	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2013
4	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2005
4	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 09/2005
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 11/2014
2	Disease Progression 11/2020 - 02/2012
2	Vomiting 04/2013 - 08/2003
1	Microsatellite Instability 04/2021
1	Obesity 11/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Overweight 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Lymphoma (Lymphomas) 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017
1	Multiple Myeloma 01/2017
1	Nausea 04/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2012
1	Febrile Neutropenia 05/2012
1	Adenocarcinoma of Lung 02/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2012
1	Adenocarcinoma 02/2012
1	Osteonecrosis (Kienbock's Disease) 07/2006
1	Pain (Aches) 07/2006
1	Bone Resorption 07/2006
1	Hypercalcemia (Milk Alkali Syndrome) 07/2006
1	Lung Neoplasms (Lung Cancer) 10/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2005
1	Rheumatoid Arthritis 09/2005
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2005
1	Neutropenia 09/2005
1	Macular Degeneration (Age-Related Maculopathy) 09/2005
1	Alopecia (Baldness) 08/2003
1	Ototoxicity 08/2003

Drug/Important Bio-Agent (IBA)

4	pertuzumabIBA 01/2021 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	XELOXIBA 01/2020 - 11/2014
3	Bevacizumab (Avastin)FDA Link 01/2013 - 09/2005
2	Ado-Trastuzumab EmtansineIBA 01/2021 - 11/2020
2	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2019
2	Gemcitabine FDA Link 06/2012 - 08/2003
2	PlatinumIBA 02/2012 - 08/2003
1	Proteins (Proteins, Gene)FDA Link 04/2021
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 04/2021
1	human ERBB2 proteinIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 11/2020
1	SteroidsIBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	AnticoagulantsIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Hormones (Hormone)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Taxoids (Taxanes)IBA 01/2019
1	Everolimus FDA Link 01/2019
1	palbociclibIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	taxaneIBA 01/2019
1	exemestane (Aromasin)FDA Link 01/2019
1	Genetic Markers (Genetic Marker)IBA 11/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2014
1	eribulin FDA Link 01/2014
1	AnthracyclinesIBA 04/2013
1	Palonosetron (Aloxi)FDA Link 04/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2012
1	Biosimilar PharmaceuticalsIBA 05/2012
1	Pemetrexed (MTA)FDA Link 02/2012
1	Diphosphonates (Bisphosphonates)IBA 07/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005
1	Retinaldehyde (Retinal)IBA 09/2005
1	Vinorelbine (Navelbine)FDA LinkGeneric 08/2003
1	Cisplatin (Platino)FDA LinkGeneric 08/2003

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2019 - 08/2003
5	Immunotherapy 04/2022 - 01/2019
3	Adjuvant Chemotherapy 01/2020 - 11/2014
3	Therapeutics 01/2019 - 07/2006
1	Tooth Extraction (Tooth Extractions) 07/2006
1	Oral Medicine 07/2006
1	Activities of Daily Living (ADL) 10/2005